Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review

Document Sample
Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review Powered By Docstoc
					             Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review

       Reference Code: GDME25538SA                                                                                        Publication Date: APR 2011

       Building 200-2, 331 Treble Cove Phone                                                            Revenue
                                                              +1 978 6679531                                              NA
       Rd.
       North Billerica, MA             Fax                    +1 978 4367501                            Net Profit        NA
       01862                                 Website          www.lantheus.com                          Employees         700 (Estimated)
       United States                         Exchange                                                   Industry          Medical Equipment

      Company Overview
       Lantheus Medical Imaging, Inc. (Lantheus Medical) is engaged in the research, development and marketing of medical imaging
       products for nuclear and ultrasound cardiovascular diagnostic imaging procedures. The company offers Cardiolite, TechneLite
       and DEFINITY. The company's DEFINITY is a cardiac ultrasound contrast agent. Its Cardiolite is a cardiac perfusion imaging
       agent. Lantheus operates in the US, Puerto Rico, Canada, and Australia. It was formerly known as Bristol-Myers Squibb Medical
       Imaging, Inc. The products offered by the company are approved by the FDA. Lantheus Medical is headquartered in
       Massachusetts, the US.

      Key Executives                                                SWOT Analysis
               Name                          Title                  Lantheus Medical Imaging, Inc., SWOT Analysis
      Larry Pickering             Chairman                          Strengths                         Weaknesses

      Don Kiepert                 Chief Executive Officer
                                                                    Strategic Acquisitions                      DEFINITY - Side Effects
      Peter Card                  Vice President,
                                  Corporate Development             Pioneering Product Portfolio
      William Dawes               Vice President,
                                  Manufacturing and
                                  Operation
                                                                    Opportunities                              Threats
      Michael P. Duffy            General Counsel
      Source: Company Website, Primary and Secondary Research,
      GlobalData                                                    Supply Chain Diversification                Industry Consolidation Challenges
                                                                    Strategy
                                                                                                                Cost Containment Pressures
      Key Competitors                                               Global Expansion

      GE Healthcare
      Bayer Schering Pharma AG                                       Source: Company Website, Primary and Secondary Research, GlobalData
      Covidien plc
      Bracco S.p.A.
      Philips Healthcare
      Source: Company Website, Primary and Secondary Research,
      GlobalData




      Recent Developments
      Jan 18, 2011:                          Lantheus Promotes Robert Gaffey To CFO
      Jul 08, 2010:                          MDS Nordion Signs New Contract With Lantheus Medical Imaging For Supply Of Molybdenum-
                                             99
      Jun 07, 2010:                          Lantheus Medical Imaging Presents Preliminary Data Comparing Novel Cardiac PET Imaging
                                             Agent With SPECT At SNM Annual Meeting
      Apr 22, 2010:                          Lantheus Medical Imaging Appoints Dana S. Washburn As Vice President, Clinical Development
                                             And Medical Affairs
      Feb 17, 2010:                          Lantheus Medical Imaging Appoints Robert A. Spurr As Vice President, Sales And Marketing
      Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData




Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review                                                                    Reference Code: GDME25538SA

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
      Table of Contents
      Table of Contents........................................................................................................................................................................................................... 2
      List of Tables .................................................................................................................................................................................................................. 4
      Section 1 - About the Company ..................................................................................................................................................................................... 5
      Lantheus Medical Imaging, Inc. - Key Facts .................................................................................................................................................................. 5
      Lantheus Medical Imaging, Inc. - Key Employees ......................................................................................................................................................... 6
      Lantheus Medical Imaging, Inc. - Key Employee Biographies ....................................................................................................................................... 7
      Lantheus Medical Imaging, Inc. - Major Products and Services .................................................................................................................................... 8
      Lantheus Medical Imaging, Inc. - History ....................................................................................................................................................................... 9
      Lantheus Medical Imaging, Inc. - Company Statement ............................................................................................................................................... 10
      Lantheus Medical Imaging, Inc. - Locations And Subsidiaries..................................................................................................................................... 11
            Head Office............................................................................................................................................................................................................ 11
            Other Locations & Subsidiaries ............................................................................................................................................................................. 11
      Section 2 – Company Analysis .................................................................................................................................................................................... 12
      Lantheus Medical Imaging, Inc. - Business Description............................................................................................................................................... 12
      Lantheus Medical Imaging, Inc. - Corporate Strategy.................................................................................................................................................. 13
      Lantheus Medical Imaging, Inc. - SWOT Analysis ....................................................................................................................................................... 14
            SWOT Analysis - Overview ................................................................................................................................................................................... 14
            Lantheus Medical Imaging, Inc. - Strengths .......................................................................................................................................................... 14
                  Strength - Strategic Acquisitions ..................................................................................................................................................................... 14
                  Strength - Pioneering Product Portfolio........................................................................................................................................................... 14
                  Strength - Innovation and Research and Development .................................................................................................................................. 14
            Lantheus Medical Imaging, Inc. - Weaknesses ..................................................................................................................................................... 14
                  Weakness - DEFINITY - Side Effects ............................................................................................................................................................. 14
            Lantheus Medical Imaging, Inc. - Opportunities .................................................................................................................................................... 15
                  Opportunity - Supply Chain Diversification Strategy ....................................................................................................................................... 15
                  Opportunity - Global Expansion ...................................................................................................................................................................... 15
                  Opportunity - New Product Launches and Strong Pipeline............................................................................................................................. 15
                  Opportunity - Growth Potential in Emerging Economies................................................................................................................................. 15
                  Opportunity - Growing Global Contrast Media Market .................................................................................................................................... 16
            Lantheus Medical Imaging, Inc. - Threats.............................................................................................................................................................. 16
                  Threat - Industry Consolidation Challenges .................................................................................................................................................... 16
                  Threat - Cost Containment Pressures............................................................................................................................................................. 16
                  Threat - Stringent Government Regulations ................................................................................................................................................... 16
                  Threat - Healthcare Reform Bill....................................................................................................................................................................... 16
      Lantheus Medical Imaging, Inc. - Key Competitors...................................................................................................................................................... 17
      Section 3 – Company’s Lifesciences Financial Deals and Alliances ........................................................................................................................... 18
            Lantheus Medical Imaging, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011 .................................................................................... 18
            Lantheus Medical Imaging, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011.................................................................................... 19
      Lantheus Medical Imaging, Inc., Recent Deals Summary ........................................................................................................................................... 20
      Section 4 – Company’s Recent Developments............................................................................................................................................................ 21
                  Jan 18, 2011: Lantheus Promotes Robert Gaffey To CFO ............................................................................................................................. 21
                  Jul 08, 2010: MDS Nordion Signs New Contract With Lantheus Medical Imaging For Supply Of Molybdenum-99 ....................................... 21
                  Jun 07, 2010: Lantheus Medical Imaging Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT At SNM
                  Annual Meeting ............................................................................................................................................................................................... 21
                  Apr 22, 2010: Lantheus Medical Imaging Appoints Dana S. Washburn As Vice President, Clinical Development And Medical Affairs........ 22
                  Feb 17, 2010: Lantheus Medical Imaging Appoints Robert A. Spurr As Vice President, Sales And Marketing ............................................. 23
                  Jan 20, 2010: Lantheus Launches ABLAVAR, A New Diagnostic Magnetic Resonance Angiography Agent ............................................... 23
                  Jan 20, 2010: Lantheus Medical Unveils New Diagnostic MRA Agent, Ablavar.....
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:139
posted:8/16/2010
language:English
pages:25
Description: Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review Summary Lantheus Medical Imaging, Inc. (Lantheus Medical) is engaged in the research, development and marketing of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures. The company offers Cardiolite, TechneLite and DEFINITY. The company's DEFINITY is a cardiac ultrasound contrast agent. Its Cardiolite is a cardiac perfusion imaging agent. Lantheus operates in the US, Puerto Rico, Canada, and Australia. It was formerly known as Bristol-Myers Squibb Medical Imaging, Inc. The products offered by the company are approved by the FDA. Lantheus Medical is headquartered in Massachusetts, the US. Lantheus Medical Imaging, Inc. Key Recent Developments… Jan 18, 2011: Lantheus Promotes Robert Gaffey To CFO Jul 08, 2010: MDS Nordion Signs New Contract With Lantheus Medical Imaging For Supply Of Molybdenum-99 Jun 07, 2010: Lantheus Medical Imaging Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT At SNM Annual Meeting Apr 22, 2010: Lantheus Medical Imaging Appoints Dana S. Washburn As Vice President, Clinical Development And Medical Affairs Feb 17, 2010: Lantheus Medical Imaging Appoints Robert A. Spurr As Vice President, Sales And Marketing GlobalData’s Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s busin
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.